MedAdvisor Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Rick Ratliff

Chief executive officer

AU$1.5m

Total compensation

CEO salary percentage	46.9%
CEO tenure	2.3yrs
CEO ownership	n/a
Management average tenure	2.1yrs
Board average tenure	6yrs

Recent management updates

Recent updates

Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now

Nov 09

Is MedAdvisor (ASX:MDR) A Risky Investment?

Oct 11

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

Mar 08

MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain

Feb 10

What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?

Jan 18

The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares

Dec 22

What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?

Dec 18

Here's Why We're Not Too Worried About MedAdvisor's (ASX:MDR) Cash Burn Situation

Nov 22

CEO Compensation Analysis

How has Rick Ratliff's remuneration changed compared to MedAdvisor's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	AU$2m	AU$723k	AU$792k
Mar 31 2024	n/a	n/a	-AU$4m
Dec 31 2023	n/a	n/a	-AU$9m
Sep 30 2023	n/a	n/a	-AU$10m
Jun 30 2023	AU$2m	AU$678k	-AU$11m

Compensation vs Market: Rick's total compensation ($USD995.82K) is above average for companies of similar size in the Australian market ($USD295.69K).

Compensation vs Earnings: Rick's compensation has been consistent with company performance over the past year.

CEO

Rick Ratliff

2.3yrs

Tenure

AU$1,542,426

Compensation

Mr. Richard Ratliff, also known as Rick, MBA IT, BChE serves as Chief Executive Officer & Managing Director and Director at MedAdvisor Limited since July 15, 2022. He serves as Chief Commercial Officer at...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Richard Ratliff	CEO, MD & Director	2.3yrs	AU$1.54m	no data
Ancila Desai	CFO & Joint Company Secretary	2.1yrs	AU$837.50k	no data
Craig Schnuriger	Acting Chief Technology Officer	4.7yrs	no data	no data
James Rotsart	Executive VP of US & Client Relations	no data	no data	no data
Wayne Marinoff	President of ANZ	1.8yrs	no data	no data
Anshu Raghuvanshi	Joint Company Secretary	1.7yrs	no data	no data

2.1yrs

Average Tenure

Experienced Management: MDR's management team is considered experienced (2.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Richard Ratliff	CEO, MD & Director	2.3yrs	AU$1.54m	no data
Linda Jenkinson	Independent Non-Executive Chairman	2.8yrs	AU$531.73k	no data
Kevin Hutchinson	Independent Non-Executive Director	2yrs	AU$187.69k	0.071% A$ 116.2k
Lucas Merrow	Independent Non-Executive Director	3.3yrs	AU$137.93k	0.17% A$ 277.4k
Sandra Hook	Independent Non-Executive Director	8.8yrs	AU$202.69k	0.056% A$ 91.3k
Arthur Charlaftis	Member of Advisory Board	8.7yrs	no data	no data
Jim Xenos	Non-Executive Director	9yrs	AU$88.46k	1.25% A$ 2.0m
Mike Da Gama	Member of Advisory Board	8.7yrs	AU$25.89k	no data
Philip England	Member of Advisory Board	8.7yrs	no data	no data
Catherine Hill	Independent Non-Executive Director	1.5yrs	AU$131.68k	no data

6.0yrs

Average Tenure

Experienced Board: MDR's board of directors are considered experienced (6 years average tenure).

MedAdvisor Management

Management criteria checks 3/4

Key information

Recent management updates

MedAdvisor Limited Announces the Resignation of Anthony Tassone as Non-Executive Director

MedAdvisor Limited, Annual General Meeting, Nov 14, 2024

MedAdvisor Limited Announces Board Resignations

Non-Executive Director recently bought AU$1.2m worth of stock

MedAdvisor Limited, Annual General Meeting, Nov 28, 2023

MedAdvisor Limited Announces Board Changes

Recent updates

New minor risk - Share price stability

New minor risk - Market cap size

Lacklustre Performance Is Driving MedAdvisor Limited's (ASX:MDR) Low P/S

MedAdvisor Limited Announces the Resignation of Anthony Tassone as Non-Executive Director

MedAdvisor Limited, Annual General Meeting, Nov 14, 2024

Full year 2024 earnings: EPS exceeds analyst expectations

MedAdvisor Limited Announces Board Resignations

Forecast breakeven date pushed back to 2025

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

Price target increased by 13% to AU$0.51

Consensus EPS estimates upgraded to AU$0.0033 loss

Forecast breakeven date moved forward to 2025

Consensus EPS estimates fall by 11%, revenue upgraded

Why Investors Shouldn't Be Surprised By MedAdvisor Limited's (ASX:MDR) Low P/S

Are Investors Undervaluing MedAdvisor Limited (ASX:MDR) By 44%?

Forecast breakeven date pushed back to 2026

New minor risk - Profitability

Now 24% overvalued after recent price rise

Consensus estimates of losses per share improve by 33%

Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?

Non-Executive Director recently bought AU$1.2m worth of stock

MedAdvisor Limited, Annual General Meeting, Nov 28, 2023

Consensus estimates of losses per share improve by 32%

Full year 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 50%

MedAdvisor Limited Announces Board Changes

Health Check: How Prudently Does MedAdvisor (ASX:MDR) Use Debt?

Consensus EPS estimates fall by 80%, revenue upgraded

First half 2023 earnings released: EPS: AU$0.009 (vs AU$0.02 loss in 1H 2022)

Price target increased to AU$0.40

MedAdvisor Limited Provides Revenue Guidance for the First Half of the Fiscal Year 2023

MedAdvisor Limited Appoints Kevin Hutchinson as Director

Less than half of directors are independent

MedAdvisor Limited to Report Q1, 2023 Results on Oct 28, 2022

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited, Annual General Meeting, Nov 30, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

MedAdvisor Limited (ASX:MDR) entered a binding agreement to acquire GuildLink Pty Ltd from Guild Group Holdings Limited for AUD 8 million.

MedAdvisor Limited Announces Executive Changes

MedAdvisor (ASX:MDR) Is Carrying A Fair Bit Of Debt

MedAdvisor Limited Announces Change of Managing Director

Price target decreased to AU$0.40

No longer forecast to breakeven

Less than half of directors are independent

MedAdvisor Limited Announces Retirement of Robert Read as CEO

Consensus forecasts updated

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited to Report First Half, 2022 Results on Feb 25, 2022

MedAdvisor Limited Appoints Raeann Grossman to the Board as A Non-Executive Director

Independent Non-Executive Director Peter Bennetto has left the company

Non-Executive Director recently sold AU$2.5m worth of stock

Increases to MedAdvisor Limited's (ASX:MDR) CEO Compensation Might Cool off for now

Is MedAdvisor (ASX:MDR) A Risky Investment?

Less than half of directors are independent

Full year 2021 earnings released

Non-Executive Director has left the company

MedAdvisor Limited announced that it has received AUD 5.25 million in funding

New 90-day low: AU$0.34

Is MedAdvisor (ASX:MDR) Using Too Much Debt?

First half 2021 earnings released: AU$0.029 loss per share (vs AU$0.024 loss in 1H 2020)

MedAdvisor Limited to Report First Half, 2021 Results on Feb 25, 2021

MedAdvisor (ASX:MDR) Shareholders Have Enjoyed A 41% Share Price Gain

What Can We Make Of MedAdvisor's (ASX:MDR) CEO Compensation?

New 90-day low: AU$0.34

Non-Executive Chairman of the Board recently bought AU$70k worth of stock

The Non-Executive Chairman of the Board of MedAdvisor Limited (ASX:MDR), Christopher Ridd, Just Bought A Few More Shares

MedAdvisor Limited Signs an Additional One-Year Deal with A Major Global Pharmaceutical Company

What Kind Of Investors Own Most Of MedAdvisor Limited (ASX:MDR)?

New 90-day low: AU$0.36